A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases
Clinical and Translational Allergy · 2024-02 · 14 (2)
DOI: 10.1002/clt2.12339 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Allergy, online erschienen am 11.02.2024. Verfasst von Purevsuren Losol und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland research center, Swiss National Science Foundation (SNSF), National Science Centre.
Abstract (Originalsprache)
Background
Allergic diseases, including respiratory and food allergies, as well as allergic skin conditions have surged in prevalence in recent decades. In allergic diseases, the gut microbiome is dysbiotic, with reduced diversity of beneficial bacteria and increased abundance of potential pathogens. Research findings suggest that the microbiome, which is highly influenced by environmental and dietary factors, plays a central role in the development, progression, and severity of allergic diseases. The microbiome generates metabolites, which can regulate many of the host’s cellular metabolic processes and host immune responses. Aims and Methods Our goal is to provide a narrative and comprehensive literature review of the mechanisms through which microbial metabolites regulate host immune function and immune metabolism both in homeostasis and in the context of allergic diseases. Results and Discussion We describe key microbial metabolites such as short‐chain fatty acids, amino acids, bile acids and polyamines, elucidating their mechanisms of action, cellular targets and their roles in regulating metabolism within innate and adaptive immune cells. Furthermore, we characterize the role of bacterial metabolites in the pathogenesis of allergic diseases including allergic asthma, atopic dermatitis and food allergy.
Conclusion
Future research efforts should focus on investigating the physiological functions of microbiota‐derived metabolites to help develop new diagnostic and therapeutic interventions for allergic diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Molecular Biology and Genetics, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
- Laboratory of Host-Microbiota Interactions, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
- APC Microbiome Ireland, University College Cork, Cork, Ireland.
- Department of Medicine, University College Cork, Cork, Ireland.
- School of Microbiology, University College Cork, Cork, Ireland.
ORCID-Profile: Purevsuren Losol, Magdalena Wolska
Förderung
- Science Foundation Ireland research center
- Swiss National Science Foundation (SNSF)
- National Science Centre
- Science Foundation Ireland Frontiers for the Future Award
Zitieren
APA
Losol, P., Wolska, M., Wypych, T. P., Yao, L., O'Mahony, L., & Sokolowska, M. (2024). A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases. Clinical and Translational Allergy, 14(2). https://doi.org/10.1002/clt2.12339
Vancouver
Losol P, Wolska M, Wypych TP, Yao L, O'Mahony L, Sokolowska M. A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases. Clinical and Translational Allergy. 2024;14(2). doi:10.1002/clt2.12339
BibTeX
@article{Losol2024,
author = {Losol, Purevsuren and Wolska, Magdalena and Wypych, Tomasz P and Yao, Lu and O'Mahony, Liam and Sokolowska, Milena},
title = {A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases},
journal = {Clinical and Translational Allergy},
year = {2024},
volume = {14},
number = {2},
doi = {10.1002/clt2.12339}
}
EUVIMED